Account
Articles
08.10.2025
Orchestrating Evidence Needs: Overcoming Regulator...

Optimising evidence generation in trial design, while navigating regulatory and local payer requirem...

Read more
Articles
01.10.2025
MFN Drug Pricing Proposal: What It Could Mean for ...

Negotiations between the Trump administration and pharmaceutical companies on lowering U.S...

Read more
Guide
08.09.2025
The BRAVE Approach: Your Guide to Early Payer Scie...

Successfully navigating early payer scientific advice whether through Joint Scientific Consultations...

Read more
Articles
03.09.2025
Proving LongTerm Value: Evidence Strategies Payers...

Proving the long-term value of pharmaceutical assets remains one of the biggest challenges for manuf...

Read more
Webinar
28.05.2025
Navigating Early Scientific Advice for Pricing and...

Whether you’re in drug development, market access, or health economics, early scientific advic...

Read more
06.03.2025
How to navigate early payer scientific advice: a B...

Charlie Hewitt from Remap Consulting initiated today’s session by providing a description of the c...

Read more
Articles
13.12.2023
Reflecting on the Pricing & Market Access tre...

Back in January this year, we summarised the key trends our market access experts believed would dom...

Read more
Articles
08.08.2023
How to get payer scientific advice between now and...

Our market access experts provide an overview of how to get payer scientific advice between Septembe...

Read more
Case Studies
27.01.2023
Payer value proposition development

Payer value proposition development and understanding evidence requirements to secure pricing and re...

Read more
Articles
26.01.2023
What have we learned from the UK EAMS process?

Almost a decade after it's inception, what have we learned from the UK early access to medicines sch...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.